Literature DB >> 8488569

The Cheng-Prusoff relationship: something lost in the translation.

D A Craig1.   

Abstract

For a variety of reasons, pharmacologists often construct 'inhibition curves' to evaluate antagonists rather than employing the more comprehensive 'Schild analysis'. There is a widespread perception that it is only possible to derive antagonist Kb values from such experiments via application of the Cheng-Prusoff equation, requiring knowledge of the agonist affinity at the receptor. In this article, Douglas Craig presents a practical examination of 'inhibition curve' methodology and demonstrates that it is a related equation requiring no knowledge of agonist affinity, rather than the Cheng-Prusoff equation, that affords theoretically valid estimates of antagonist Kb values from this technique.

Mesh:

Year:  1993        PMID: 8488569     DOI: 10.1016/0165-6147(93)90070-z

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  25 in total

1.  CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.

Authors:  K E Kenworthy; J C Bloomer; S E Clarke; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.

Authors:  M D Wood; K L Murkitt; S Q Rice; T Testa; P K Punia; M Stammers; O Jenkins; N A Elshourbagy; U Shabon; S J Taylor; T L Gager; J Minton; W D Hirst; G W Price; M Pangalos
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.

Authors:  R L Jones; D F Woodward; J W Wang; R L Clark
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits.

Authors:  S C Harvey; C W Luetje
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

5.  Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer.

Authors:  Amy E Schmidt; Kanagasabai Vadivel; Julian Whitelegge; Satya Paul Bajaj
Journal:  J Thromb Haemost       Date:  2020-03-30       Impact factor: 5.824

Review 6.  Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery.

Authors:  Marcus J C Long; Dziyana Hnedzko; Bo Kyoung Kim; Yimon Aye
Journal:  Chembiochem       Date:  2019-04-01       Impact factor: 3.164

7.  Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.

Authors:  I K Wright; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

Review 8.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

9.  The turkey erythrocyte beta-adrenergic receptor couples to both adenylate cyclase and phospholipase C via distinct G-protein alpha subunits.

Authors:  S R James; C Vaziri; T R Walker; G Milligan; C P Downes
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding.

Authors:  R Z Cer; U Mudunuri; R Stephens; F J Lebeda
Journal:  Nucleic Acids Res       Date:  2009-04-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.